Literature DB >> 21529843

Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice.

Susan S Kim1, David P Richman, Scott S Zamvil, Mark A Agius.   

Abstract

B cell activating factor (BAFF) is critical for B cell survival, a function that is mediated by BAFF receptor, (BAFF-R). The role of BAFF (or BAFF-R) in the multiple sclerosis model, experimental autoimmune encephalomyelitis (EAE), was examined using BAFF-R-deficient mice. BAFF-R deficiency resulted in paradoxically increased severity of EAE induced by myelin-oligodendrocyte glycoprotein (MOG) peptide 35-55. Inflammatory foci in BAFF-R-deficient mice comprised increased numbers of activated macrophages expressing BAFF and correlated with increased BAFF secretion. Thus, BAFF-R may be important in EAE pathogenesis, possibly by influencing macrophage function through a mechanism that involves modulation of BAFF expression. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529843      PMCID: PMC4172440          DOI: 10.1016/j.jns.2011.04.008

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  22 in total

1.  BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.

Authors:  J S Thompson; S A Bixler; F Qian; K Vora; M L Scott; T G Cachero; C Hession; P Schneider; I D Sizing; C Mullen; K Strauch; M Zafari; C D Benjamin; J Tschopp; J L Browning; C Ambrose
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

2.  Susceptibility to experimental autoimmune encephalomyelitis is associated with altered B-cell subsets distribution and decreased serum BAFF levels.

Authors:  Catalina Lee-Chang; Didier Lefranc; Julia Salleron; Christelle Faveeuw; Cecile Allet; Patrick Vermersch; Bénédicte Oxombre; Lionel Prin
Journal:  Immunol Lett       Date:  2010-10-12       Impact factor: 3.685

3.  Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells.

Authors:  Sung-Tak Jeon; Won-Jung Kim; Sang-Min Lee; Min-Young Lee; Seung-Beom Park; Seung-Hee Lee; In-San Kim; Kyoungho Suk; Beom Kyu Choi; Eun M Choi; Byoung S Kwon; Won-Ha Lee
Journal:  Immunol Cell Biol       Date:  2009-10-20       Impact factor: 5.126

4.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

5.  Synthesis and release of B-lymphocyte stimulator from myeloid cells.

Authors:  B Nardelli; O Belvedere; V Roschke; P A Moore; H S Olsen; T S Migone; S Sosnovtseva; J A Carrell; P Feng; J G Giri; D M Hilbert
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

6.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

Review 7.  The immunopathology of multiple sclerosis: an overview.

Authors:  Hans Lassmann; Wolfgang Brück; Claudia F Lucchinetti
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

8.  B cells regulate autoimmunity by provision of IL-10.

Authors:  Simon Fillatreau; Claire H Sweenie; Mandy J McGeachy; David Gray; Stephen M Anderton
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

9.  Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.

Authors:  Jeri-Anne Lyons; Michael J Ramsbottom; Anne H Cross
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

10.  Emerging multiple sclerosis oral therapies.

Authors:  Kottil W Rammohan; Jennifer Shoemaker
Journal:  Neurology       Date:  2010-01-05       Impact factor: 9.910

View more
  10 in total

Review 1.  TNF superfamily in inflammatory disease: translating basic insights.

Authors:  Michael Croft; Wei Duan; Heonsik Choi; So-Young Eun; Shravan Madireddi; Amit Mehta
Journal:  Trends Immunol       Date:  2011-12-13       Impact factor: 16.687

Review 2.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 3.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

4.  Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity.

Authors:  Debra D Bloom; Sofiya Reshetylo; Cassandra Nytes; Claudia T Goodsett; Peiman Hematti
Journal:  J Immunother       Date:  2018-06       Impact factor: 4.456

Review 5.  Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets.

Authors:  H-Christian von Büdingen; Arumugam Palanichamy; Klaus Lehmann-Horn; Brady A Michel; Scott S Zamvil
Journal:  Eur Neurol       Date:  2015-03-25       Impact factor: 1.710

Review 6.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

Review 7.  Clinical targeting of the TNF and TNFR superfamilies.

Authors:  Michael Croft; Chris A Benedict; Carl F Ware
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

8.  CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS.

Authors:  Gaurav Kumar; Zahra Maria; Uday Kohli; Agnieshka Agasing; James L Quinn; Rose M Ko; Scott S Zamvil; Robert C Axtell
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-03-01

Review 9.  Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.

Authors:  Sandip Sonar; Girdhari Lal
Journal:  Front Immunol       Date:  2015-07-20       Impact factor: 7.561

Review 10.  Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface.

Authors:  Won-Ha Lee; Donggun Seo; Su-Geun Lim; Kyoungho Suk
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.